Cryptic infection and autoimmunity

Autoimmunity Reviews

Volumn 2, Issue 3, 2003, Pages 126-132

  Pleister, Adam ^a   Eckels, David D ^a  

^a CHILDREN S HOSPITAL OF WISCONSIN   (United States)

Author keywords

Autoimmunity; Diabetes; HCV; Infection

Indexed keywords

ANTIGEN EXPRESSION; AUTOIMMUNITY; CROSS REACTION; ENTEROVIRUS; ENVIRONMENTAL FACTOR; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; REVIEW; VIROGENESIS; VIRUS REPLICATION; ANIMAL; BIOLOGICAL MODEL; IMMUNOLOGY; INFECTION;

ANIMALS; AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; HEPACIVIRUS; HUMANS; INFECTION; MODELS, IMMUNOLOGICAL;

EID: 0141484442     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1568-9972(03)00003-X     Document Type: Review

References (38)

1. Robles D.T., Eisenbarth G.S. Type 1A diabetes induced by infection and immunization. J Autoimmun. 16:(3):2001;355-362.
2. Gale E.A. The discovery of type 1 diabetes. Diabetes. 50:(2):2001;217-226.
3. Oldstone M.B. Molecular mimicry and autoimmune disease. Cell. 50:(6):1987;819-820.
4. Yoon J.W. The role of viruses and environmental factors in the induction of diabetes. Curr Top Microbiol Immunol. 164:1990;95-123.
5. Souan L., Margalit R., Brenner O., Cohen I.R., Mor F. Self prion protein peptides are immunogenic in Lewis rats. J Autoimmun. 17:(4):2001;303-310.
6. Oldstone M.B. Molecular mimicry and immune-mediated diseases. FASEB J. 12:(13):1998;1255-1265.
7. Guilherme L., Cunha-Neto E., Coelho V., et al. Human heart-infiltrating T-cell clones from rheumatic heart disease patients recognize both streptococcal and cardiac proteins. Circulation. 92:(3):1995;415-420.
8. Oomes P.G., Jacobs B.C., Hazenberg M.P., Banffer J.R., van der Meche F.G. Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barre syndrome: evidence of molecular mimicry. Ann Neurol. 38:(2):1995;170-175.
9. Yuki N., Tagawa Y., Handa S. Autoantibodies to peripheral nerve glycosphingolipids SPG, SLPG, and SGPG in Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol. 70:(1):1996;1-6.
10. Atkinson M.A., Bowman M.A., Campbell L., Darrow B.L., Kaufman D.L., Maclaren N.K. Cellular immunity to a determinant common to glutamate decarboxylase and Coxsackie virus in insulin-dependent diabetes. J Clin Invest. 94:(5):1994;2125-2129.
11. Wucherpfennig K.W., Strominger J.L. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell. 80:(5):1995;695-705.
12. Sercarz E.E., Lehmann P.V., Ametani A., Benichou G., Miller A., Moudgil K. Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol. 11:1993;729-766.
13. Miller S.D., Vanderlugt C.L., Begolka W.S., et al. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat Med. 3:(10):1997;1133-1136.
14. Luz J.G., Huang M., Garcia K.C., et al. Structural comparison of allogeneic and syngeneic T cell receptor-peptide-major histocompatibility complex complexes: a buried alloreactive mutation subtly alters peptide presentation substantially increasing V(beta) interactions. J Exp Med. 195:(9):2002;1175-1186.
15. Horwitz M.S., Bradley L.M., Harbertson J., Krahl T., Lee J., Sarvetnick N. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med. 4:(7):1998;781-785.
16. Goverman J., Woods A., Larson L., Weiner L.P., Hood L., Zaller D.M. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell. 72:(4):1993;551-560.
17. Kubo S., Nakayama T., Furutani-Seiki M., et al. A novel form of self tolerance dictated in the thymus of transgenic mice with autoreactive TCR alpha and beta chain genes. Int Immunol. 6:(4):1994;593-602.
18. Mueller R., Bradley L.M., Krahl T., Sarvetnick N. Mechanism underlying counterregulation of autoimmune diabetes by IL-4. Immunity. 7:(3):1997;411-418.
19. Anderson M.S., Venanzi E.S., Klein L., et al. Projection of an immunological self shadow within the thymus by the aire protein. Science. 298:(5597):2002;1395-1401.
20. Janeway C.A. Jr. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol. 54:(Pt 1):1989;1-13.
21. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol. 12:1994;991-1045.
22. Flodstrom M., Maday A., Balakrishna D., Cleary M.M., Yoshimura A., Sarvetnick N. Target cell defense prevents the development of diabetes after viral infection. Nat Immunol. 3:(4):2002;373-382.
23. Janeway C.A. Jr. How the immune system works to protect the host from infection: a personal view. Proc Natl Acad Sci USA. 98:(13):2001;7461-7468.
24. Medzhitov R., Janeway C.A. Jr. Decoding the patterns of self and nonself by the innate immune system. Science. 296:(5566):2002;298-300.
25. Beutler B. Toll-like receptors: how they work and what they do. Curr Opin Hematol. 9:(1):2002;2-10.
26. Matzinger P. The danger model: a renewed sense of self. Science. 296:(5566):2002;301-305.
27. Gallucci S., Matzinger P. Danger signals: SOS to the immune system. Curr Opin Immunol. 13:(1):2001;114-119.
28. Horwitz M.S., Sarvetnick N. Viruses, host responses, and autoimmunity. Immunol Rev. 169:1999;241-253.
29. Eckels D.D., Wang H., Bian T-H., Tabatabai N., Gill J.C. Immunobiology of hepatitis C virus infection: The role of CD4 T-cells in HCV infection. Immunol Rev. 174:2000;90-97.
30. Alvarez F., Berg P.A., Bianchi F.B., et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 31:(5):1999;929-938.
31. Choo Q.L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 244:1989;359-362.
32. Foulis A.K., McGill M., Farquharson M.A., Hilton D.A. A search for evidence of viral infection in pancreases of newly diagnosed patients with IDDM. Diabetologia. 40:(1):1997;53-61.
33. Foulis A.K., Farquharson M.A., Meager A. Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus. Lancet. 2:(8573):1987;1423-1427.
34. Chehadeh W., Weill J., Vantyghem M.C., et al. Increased level of interferon-alpha in blood of patients with insulin-dependent diabetes mellitus: relationship with Coxsackie virus B infection. J Infect Dis. 181:(6):2000;1929-1939.
35. Chehadeh W., Kerr-Conte J., Pattou F., et al. Persistent infection of human pancreatic islets by Coxsackie virus B is associated with alpha interferon synthesis in beta cells. J Virol. 74:(21):2000;10153-10164.
36. Conrad B., Weissmahr R.N., Boni J., Arcari R., Schupbach J., Mach B. A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes. Cell. 90:(2):1997;303-313.
37. Stauffer Y., Marguerat S., Meylan F., et al. Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity. Immunity. 15:(4):2001;591-601.
38. Badenhoop K., Tonjes R.R., Rau H., et al. Endogenous retroviral long terminal repeats of the HLA-DQ region are associated with susceptibility to insulin-dependent diabetes mellitus. Hum Immunol. 50:(2):1996;103-110.